COL1A1 is a type of collagen (COL) that has been reported to be upregulated in ESCC (Li et al., 2019) and may contribute to paclitaxel and topotecan resistance in ovarian cancer cells (Januchowski et al., 2016). The gene discussed is COL1A1; the disease is ovarian carcinoma.